1
|
Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcription.
|
Stroke
|
2008
|
1.72
|
2
|
Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.
|
Mol Pharmacol
|
2006
|
1.67
|
3
|
The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension.
|
Trends Pharmacol Sci
|
2005
|
1.34
|
4
|
Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction.
|
J Biol Chem
|
2005
|
1.33
|
5
|
Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool.
|
J Biol Chem
|
2010
|
1.27
|
6
|
Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo.
|
Neurobiol Dis
|
2009
|
1.16
|
7
|
STAT1 is activated in neurons after ischemia and contributes to ischemic brain injury.
|
J Cereb Blood Flow Metab
|
2002
|
1.08
|
8
|
Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia.
|
J Cereb Blood Flow Metab
|
2012
|
1.08
|
9
|
Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis.
|
Mol Pharmacol
|
2011
|
1.07
|
10
|
Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage.
|
Adv Exp Med Biol
|
2003
|
1.04
|
11
|
Ischemic neuroprotection by TRPV1 receptor-induced hypothermia.
|
J Cereb Blood Flow Metab
|
2012
|
1.03
|
12
|
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure.
|
J Biol Chem
|
2009
|
1.03
|
13
|
Functional study in a yeast model of a novel succinate dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor.
|
Hum Mol Genet
|
2009
|
1.01
|
14
|
Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice.
|
J Cereb Blood Flow Metab
|
2006
|
1.01
|
15
|
Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription.
|
Mol Pharmacol
|
2011
|
1.00
|
16
|
Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines.
|
Eur J Immunol
|
2006
|
0.95
|
17
|
Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo.
|
Biochem Pharmacol
|
2009
|
0.95
|
18
|
Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria.
|
PLoS One
|
2013
|
0.94
|
19
|
Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment.
|
FEBS J
|
2009
|
0.93
|
20
|
A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation.
|
J Immunol
|
2007
|
0.92
|
21
|
Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism.
|
Anesthesiology
|
2006
|
0.92
|
22
|
Neither energy collapse nor transcription underlie in vitro neurotoxicity of poly(ADP-ribose) polymerase hyper-activation.
|
Neurochem Int
|
2006
|
0.90
|
23
|
The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis.
|
Mol Med
|
2011
|
0.90
|
24
|
Inhibition of poly(ADP-ribose) glycohydrolase by gallotannin selectively up-regulates expression of proinflammatory genes.
|
Mol Pharmacol
|
2004
|
0.89
|
25
|
Induction of CD83+CD14+ nondendritic antigen-presenting cells by exposure of monocytes to IFN-alpha.
|
J Immunol
|
2008
|
0.89
|
26
|
Nuclear factor-kappaB as a molecular target for migraine therapy.
|
Ann Neurol
|
2002
|
0.89
|
27
|
PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.
|
Mult Scler
|
2011
|
0.88
|
28
|
High expression of indoleamine 2,3-dioxygenase gene in prostate cancer.
|
Eur J Cancer
|
2008
|
0.86
|
29
|
AMP-dependent hypothermia affords protection from ischemic brain injury.
|
J Cereb Blood Flow Metab
|
2012
|
0.86
|
30
|
18β-glycyrrhetic acid inhibits immune activation triggered by HMGB1, a pro-inflammatory protein found in the tear fluid during conjunctivitis and blepharitis.
|
Ocul Immunol Inflamm
|
2011
|
0.85
|
31
|
Antidromic vasodilatation and the migraine mechanism.
|
J Headache Pain
|
2011
|
0.85
|
32
|
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives.
|
ChemMedChem
|
2008
|
0.84
|
33
|
Poly(ADP-ribosyl)ation regulates heat shock factor-1 activity and the heat shock response in murine fibroblasts.
|
Biochem Cell Biol
|
2006
|
0.84
|
34
|
Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage.
|
Toxicol Lett
|
2003
|
0.83
|
35
|
Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?
|
Trends Mol Med
|
2011
|
0.83
|
36
|
1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-κB/RelA acetylation at Lys310.
|
PLoS One
|
2012
|
0.82
|
37
|
Activation of the histaminergic H3 receptor induces phosphorylation of the Akt/GSK-3 beta pathway in cultured cortical neurons and protects against neurotoxic insults.
|
J Neurochem
|
2009
|
0.82
|
38
|
Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes.
|
J Invest Dermatol
|
2009
|
0.81
|
39
|
Brain ischemic preconditioning does not require PARP-1.
|
Stroke
|
2009
|
0.81
|
40
|
Relevance of high-mobility group protein box 1 to neurodegeneration.
|
Int Rev Neurobiol
|
2007
|
0.80
|
41
|
Human Langerhans cells are immature in melanoma sentinel lymph nodes.
|
Blood
|
2012
|
0.80
|
42
|
Anticonvulsant effect of AMP by direct activation of adenosine A1 receptor.
|
Exp Neurol
|
2013
|
0.79
|
43
|
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation.
|
Horm Cancer
|
2014
|
0.77
|
44
|
Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance.
|
Eur J Neurosci
|
2012
|
0.77
|
45
|
Glucose deprivation converts poly(ADP-ribose) polymerase-1 hyperactivation into a transient energy-producing process.
|
J Biol Chem
|
2013
|
0.77
|
46
|
PARP inhibition delays progression of mitochondrial encephalopathy in mice.
|
Neurotherapeutics
|
2014
|
0.76
|
47
|
Carboxymethyl beta-glucan binds to corneal epithelial cells and increases cell adhesion to laminin and resistance to oxidative stress.
|
Cornea
|
2007
|
0.75
|